Diagnostic performance of two confocal endomicroscopy systems in detecting Barrett's dysplasia: A pilot study using a novel bioprobe in ex vivo tissue

Gastrointestinal Endoscopy

Volumn 76, Issue 5, 2012, Pages 933-938

  Gorospe, Emmanuel C ^a   Leggett, Cadman L ^a   Sun, Gang ^a   Anderson, Marlys A ^a   Gupta, Milli ^a   Penfield, Joshua D ^a   Lutzke, Lori ^a   Lewis, Jason T ^a   Wong Kee Song, Louis M ^a   Wang, Kenneth K ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (N (7 NITROBENZ 2 OXA 1,3 DIAXOL 4YL)AMINO) 2 DEOXYGLUCOSE; GLUCOSE DERIVATIVE; UNCLASSIFIED DRUG; 2 (N (7 NITROBENZ 2 OXA 1,3 DIAZOL 4 YL)AMINO) 2 DEOXYGLUCOSE; 2-(N-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)AMINO)-2-DEOXYGLUCOSE; 4 CHLORO 7 NITROBENZOFURAZAN; DEOXYGLUCOSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORESCENT DYE;

AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY CANCER; ENDOSCOPE; ESOPHAGUS DYSPLASIA; EX VIVO STUDY; FEASIBILITY STUDY; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN TISSUE; MALE; MECHANICAL PROBE; PILOT STUDY; PRIORITY JOURNAL; COMPARATIVE STUDY; ESOPHAGOSCOPY; ESOPHAGUS; INSTRUMENTATION; MUCOSA; OBSERVER VARIATION; PATHOLOGY;

4-CHLORO-7-NITROBENZOFURAZAN; AGED; BARRETT ESOPHAGUS; DEOXYGLUCOSE; ESOPHAGOSCOPY; ESOPHAGUS; FEASIBILITY STUDIES; FEMALE; FLUORESCENT DYES; HUMANS; MALE; MICROSCOPY, CONFOCAL; MUCOUS MEMBRANE; OBSERVER VARIATION; PILOT PROJECTS;

EID: 84877033928     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2012.07.005     Document Type: Article

References (19)

1. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-6. (Pubitemid 40277094)
2. Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008;103:788-97. (Pubitemid 351406009)
3. Kiesslich R, Gossner L, Goetz M, et al. In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol 2006;4:979-87. (Pubitemid 44118843)
4. Wallace M, Lauwers GY, Chen Y, et al. Miami classification for probe-based confocal laser endomicroscopy. Endoscopy 2011;43:882-91.
5. Sharma P, Meining AR, Coron E, et al. Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc 2011;74:465-72.
6. Dabizzi E, Shahid MW, Qumseya B, et al. Comparison between video and mosaic viewing mode of confocal laser endomicroscopy (Pcle) in patients with Barrett's esophagus. Dig Liver Dis 2011;43:S186-S.
7. O'Neil RG, Wu L, Mullani N. Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells. Mol Imaging Biol 2005;7:388-92. (Pubitemid 44193403)
8. Kato H, Takita J, Miyazaki T, et al. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness. Anticancer Res 2002;22:2635-9. (Pubitemid 36069291)
9. Thekkek N, Maru DM, Polydorides AD, et al. Pre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett's-associated neoplasia during confocal imaging. Technol Cancer Res Treat 2011;10:431-41.
10. Gorospe EC, Tian J, Anderson M, et al. A potential new maker of dysplasia: 2-NBDG in Barrett's esophagus cell lines. DDW Chicago, IL, 2011. p. s1.
11. Gorospe EC, Cadman CL, Penfield JD, et al. "Optical PET scan" for the detection of Barrett's dysplasia: in vitro studies using cell lines and EMR tissue. Submitted to DDW 2012. Rochester, MN: Mayo Clinic; 2012.
12. Gaddam S, Mathur SC, Singh M, et al. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett's esophagus. Am J Gastroenterol 2011;106:1961-9.
13. Donner A, Eliasziw M. A goodness-of-fit approach to inference procedures for the kappa statistic: confidence interval construction, significance-testing and sample size estimation. Stat Med 1992;11:1511-9.
14. Fleiss J. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley & Sons; 1981.
15. Dunbar KB, Okolo P 3rd, Montgomery E, et al. Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: a prospective, randomized, double-blind, controlled, crossover trial. Gastrointest Endosc 2009;70:645-54.
16. Langsner RJ, Middleton LP, Sun J, et al. Wide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue. Biomed Opt Express 2011;2:1514-23.
17. Wallace MB, Abrams JA, Bajbouj M, et al. Accuracy and inter-observer agreement of experts for probe-based confocal laser endomicroscopy detection of dysplasia in Barrett's esophagus [abstract]. Gastrointest Endosc 2009;69:AB351.
18. Pohl H, Rösch T, Vieth M, et al. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Gut 2008;57:1648-53.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74. (Pubitemid 8054849)